Success Metrics

Clinical Success Rate
90.0%

Based on 9 completed trials

Completion Rate
90%(9/10)
Active Trials
1(6%)
Results Posted
22%(2 trials)
Terminated
1(6%)

Phase Distribution

Ph not_applicable
11
69%
Ph phase_1
4
25%
Ph phase_3
1
6%

Phase Distribution

4

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution16 total trials
Phase 1Safety & dosage
4(25.0%)
Phase 3Large-scale testing
1(6.3%)
N/ANon-phased studies
11(68.8%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

81.8%

9 of 11 finished

Non-Completion Rate

18.2%

2 ended early

Currently Active

1

trials recruiting

Total Trials

16

all time

Status Distribution
Active(5)
Completed(9)
Terminated(2)

Detailed Status

Completed9
Enrolling by invitation3
Recruiting1
Withdrawn1
Terminated1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
16
Active
1
Success Rate
90.0%
Most Advanced
Phase 3

Trials by Phase

Phase 14 (25.0%)
Phase 31 (6.3%)
N/A11 (68.8%)

Trials by Status

recruiting16%
completed956%
withdrawn16%
terminated16%
enrolling_by_invitation319%
not_yet_recruiting16%

Recent Activity

Clinical Trials (16)

Showing 16 of 16 trials
NCT05613153Not Applicable

Peppermint Oil as a Treatment for Children With Bladder and Bowel Dysfunction

Enrolling By Invitation
NCT07326163Not Applicable

The Effect of Peppermint Oil Aromatherapy on Pain, Functional Capacity and Cost in Fibromyalgia Patients

Enrolling By Invitation
NCT05561543Not Applicable

Effects of Peppermint Oil in Mild-moderate Hypertension.

Completed
NCT07318779Not Applicable

Effect of Cardamom and Peppermint Oils on Chemotherapy-Related Nausea-Vomiting and Food Intake

Not Yet Recruiting
NCT05282706Phase 1

Use of Aromatherapy in Conjunction With Physical/Occupational Therapy in an Acute Care Setting

Enrolling By Invitation
NCT06914921Not Applicable

Enteric-Coated Peppermint Oil Versus Standard Antispasmodic in SLC6A4 (5-HTTLPR) Carriers With Irritable Bowel Syndrome.

Completed
NCT02802241Not Applicable

Effects of Open-label vs Double-blind Treatment in IBS

Completed
NCT04497870Phase 1

Peppermint Oil Pharmacokinetics/Dynamics

Withdrawn
NCT05071833Not Applicable

Effects of Peppermint Oil in Cardiometabolic Outcomes

Completed
NCT05677698Not Applicable

Menoupausal Symptoms and Aromatherapy

Completed
NCT04845217Phase 1

Peppermint Oil for the Treatment of Interstitial Cystitis / Bladder Pain Syndrome

Recruiting
NCT02588248Phase 3

L-Menthol Injection as a Novel Technique During Colonoscopy

Terminated
NCT03295747Phase 1

Peppermint Oil Pharmacokinetics/Dynamics and Novel Biological Signatures in Children With Functional Abdominal Pain

Completed
NCT03286764Not Applicable

Use of Peppermint Oil During Screening Colonoscopy to Improve Visibility

Completed
NCT03577496Not Applicable

Does Aromatherapy Decrease Postoperative Nausea and Vomiting?

Completed
NCT03370328Not Applicable

Reducing Up-set Stomach and Vomiting After Surgery Using Essential Oils

Completed

All 16 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
16